Alterations of monocyte function in patients with growth hormone (GH) deficiency: Effect of substitutive GH therapy

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 1, 1999, Pages 58-63

  Serri, Omak ^a   St Jacques, Pascal ^a   Sartippour, Maryam ^a   Renier, Geneviève ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL CELL; AORTA; ARTICLE; ATHEROSCLEROSIS; CELL ACTIVATION; CELL ADHESION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HUMAN; HUMAN CELL; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; BODY COMPOSITION; CELL ADHESION; FEMALE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-6; LIPIDS; MALE; MIDDLE AGED; MONOCYTES;

ANIMALIA;

EID: 0032902249     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.1.58     Document Type: Article

References (48)

1. 1. Markussis V, Beshyah SA, Fisher C, Sharp P, Nicolaides AN, Johnston DG. 1992 Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet. 340:1188-1192.
2. 2. Rosen T, Bengtsson BA. 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 336:285-288.
3. 3. Bates AS, Van't Hoff W, Jones PJ, Clayton RN. 1996 The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab. 81:1169-1172.
4. 4. Cuneo RC, Salomon F, Watts GF et al. 1993 Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism. 42:1519-1523.
5. 5. Salomon F, Cuneo RC, Hesp R, Sonksen PH. 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med. 321:1797-1803.
6. 6. Faggiotto A, Ross R, Harker L. 1984 Studies of hypercholesterolemia in the nonhuman primate. 1. Changes that lead to fatty streak formation. Arteriosclerosis. 4:323-340.
7. 7. Pierpaoli W, Baroini C, Fabris N, Sorkin E. 1969 Reconstruction of antibody production in hormonally deficient mice by somatotrophic hormone, thyreotropic hormone and thyroxin. Immunology. 16:217-230.
8. 8. Baroni CD, Fabris N, Bertoli G. 1969 Effects of hormones on development and function of lymphoid tissues. Immunology. 17:303-314.
9. 9. Nagy E, Berczi I. Friesen HG. 1983 Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinol (Copenh) 102:351-357.
10. 10. Kiess W, Doerr H, Eisl E, Butenandt O, Belohradsky BH. 1986 Lymphocyte subsets and natural killer cell activity in growth hormone deficiency. N Engl J Med. 314:321.
11. 11. Edwards CK, Ghiassudin SM, Schepper JM, Yunger LM, Kelley KW. 1988 A newly defined property of somatotropin: priming of macrophages for production of Superoxide anion. Science. 239:769-771.
12. 12. Edwards CK, Lorence RM, Dunham DM, Arkins S, et al. 1991 Hypophysectomy inhibits the synthesis of tumor necrosis factor α by rat macrophages: partial restoration by exogenous growth hormone or Interferon-γ. Endocrinology. 128:989-996.
13. 13. Edwards CK, Yunger LM, Lorence RM, Dantzer R, Kelley KW. 1991 The pituitary gland is required for protection against lethal effects of Salmonella typhimurium. Immunology. 88:2274-2277.
14. 14. Ross R. 1993 The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:801-809.
15. 15. Mihara M, Uchiyama M. 1978 Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 86:271-278.
16. 16. Csallany AS, Der Guan M, Manwaring JD, Addis PB. 1984 Free malondialdehyde determination in tissues by high-performance liquid chromatography. Anal Biochem. 142:277-283.
17. 17. Blum WF, Albertsson-Wikland K, Rosberg S, Ranke MB. 1993 Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab 76:1610-1616.
18. 18. Boyum A. 1968 Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at Ig. Scand J Clin Lab Invest. 97:77-89.
19. 19. Bath PMW, Booth RFG, Hassall DG. 1989 Monocyte-lymphocyte discrimination in a new microtitre-based adhesion assay. J Immunol Methods. 118:59-65.
20. 20. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS. 1990 Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol. 65:297-302.
21. 21. Rus HG, Niculescu F, Vlaicu R. 1991 Tumor necrosis factor-α in human arterial wall with atherosclerosis. Atherosclerosis. 89:247-254.
22. 22. Rus HG, Vlaicu R, Niculescu F. 1996 Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis. 127:263-271.
23. 23. Seino Y, Ikeda U, Ikeda M, et al. 1994 Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine. 6:87-91.
24. 24. Cavender D, Saegusa Y, Ziff M. 1987 Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor. J Immunol. 139:1855-1860.
25. 25. Gamble JR, Harlan JM, Klebanoff SJ, Vadas MA. 1985 Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA. 82:8667-8671.
26. 26. Ming WJ, Bersani L, Mantovani A. 1987 Tumor necrosis factor-α is chemotactic for monocytes and polymorphonuclear leukocytes. J Immunol. 138;1469-1474.
27. 27. Bevilacqua MP, Gimbrone MA. 1987 Inducible endothelial functions in inflammation and coagulation. Semin Thromb Hemost. 13:425-433.
28. 28. Watson C, Whittaker S, Smith N, Vora AJ, Dumonde DC, Brown KA. 1996 IL-6 acts on endothelial cells to preferentially increase their adherence for lymphocytes. Clin Exp Immunol. 105:112-119.
29. 29. Maruo N, Morita I, Shirao M, Murota S. 1992 IL-6 increases endothelial permeability in vitro. Endocrinology. 131:710-714.
30. 30. Akira S, Kishimoto T. 1996 Role of inlerleukin-6 in macrophage function. Curr Opin Hematol. 3:87-93.
31. 31. Morimoto S, Nabata T, Koh E, et al. 1991 InterIeukin-6 stimulates proliferation of cultured vascular smooth muscle cells independently of interleukin-1 beta. J Cardiovasc Pharmacol. 17:5117-118.
32. 32. Ikeda U, Ikeda M, Oohara T, et al. 1991 Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol. 260:H1713-H1717.
33. 33. Nabata T, Morimoto S, Koh E, Shiraishi T, Ogihara T. 1990 Interleukin-6 stimulates c-myc expression and proliferation of cultured vascular smooth muscle cells. Biochem Int. 20:445-453.
34. 34. Gauldie J. Richards C, Baumann H. 1992 IL-6 and the acute reaction. Res Immunol. 143:755-759.
35. 35. Geiger T, Andus T, Klapproth J, Hirano T, Kishimoto T, Heinrich PC. 1988 Induction of rat acute-phase proteins by interleukin 6 in vivo. Eur J Immunol. 18:717-721.
36. 36. Vasse M, Paysant J, Soria J, Collet JP, Vannier JP, Soria C. 1996 Regulation of fibrinogen by cytokines, consequences on the vascular risk. Haemostasis. 26:331-339.
37. 37. Elneihoum AM, Falke P, Hedblad B, Lindgarde F, Ohlsson K. 1997 Leukocyte activation in atherosclerosis, correlation with risk factors. Atherosclerosis. 131:79-84.
38. 38. Mendall MA, Patel P, Asante M, et al. 1997 Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart. 78:273-277.
39. 39. Hooghe-Peters EL, Hooghe R. 1995 Epilogue. In: Hooghe-Peters EL, Hooghe R, eds. Growth hormone, prolactin and IGF-I as lymphohemopoietic cytokines. New York: R. G. Lanes, Austin/Springer-Verlag; 239-256.
40. 40. Wiedermann CJ, Reinisch N, Braunsteriner H. 1993 Stimulation of monocyte chemotaxis by human growth hormone and its deactivation by somatostatin. Blood. 82:954-960.
41. 41. Chen Y, Johnson AG. 1993 In vivo activation of macrophages by prolactin from young and aging mice. Int J Immunopharmacol. 15:39-45.
42. 42 Renier G, Clément I, Desfaits AC, Lambert A. 1996 Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-α production. Endocrinology. 137:4611-4618.
43. 43. Gala RR, Shevach EM. 1993 Influence of prolactin and growth hormone on the activation of dwarf mouse lymphocytes in vivo. Proc Soc Exp Biol Med. 204:224-230.
44. 44. Janssen YJ, Frolich M, Roelfsema F. 1997 A low starting dose of genotropin in growth hormone-deficient adults. J Clin Endocrinol Metab. 82:129-135.
45. 45. Whitehead HM, Boreham C, McIlrath EM, et al. 1992 Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross over study. Clin Endocrinol (Oxf). 36:45-52.
46. 46. Benglsson BA, Edén S, Lönn L, et al. 1993 Treatment of adults with growth hormone deficiency with recombinant human growth hormone. J Clin Endocrinol Metab. 76:309-317.
47. 47. Cuneo R, Judd S, Wallace J, et al. 1998 The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults. J Clin Endocrinol Metab. 83:107-116.
48. 48. Weaver JU, Monson JP, Noonan K, et al. 1995 The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. J Clin Endocrinol Metab. 80:153-159.